Nektar Therapeutics - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
NKTR Nasdaq 2834 www.nektar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Nektar Therapeutics

A Look At Nektar Therapeutics (NKTR) Valuation After Recent Share Price Volatility - Jun 6th, 2026 9:10 pm
What Makes Nektar Therapeutics (NKTR) a Promising Mid-Cap Healthcare Stock - Jun 5th, 2026 9:55 am
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 3rd, 2026 2:15 pm
Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York - May 27th, 2026 4:00 pm
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch - May 23rd, 2026 2:48 pm
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% - May 23rd, 2026 2:37 pm
Assessing Nektar Therapeutics (NKTR) Valuation After Strong REZPEG Prospects And Recent Share Price Momentum - May 12th, 2026 6:26 pm
Nektar Therapeutics Q1 2026 Earnings Call Summary - May 8th, 2026 6:30 am
Nektar Therapeutics Q1 Earnings Call Highlights - May 8th, 2026 5:07 am
Nektar (NKTR) Q1 2026 Earnings Transcript - May 7th, 2026 4:53 pm
Nektar Therapeutics Reports First Quarter 2026 Financial Results - May 7th, 2026 2:15 pm
How The Rezpegaldesleukin Story Is Recasting The Narrative For Nektar Therapeutics (NKTR) - May 2nd, 2026 10:14 am
Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets - Apr 28th, 2026 4:00 pm
Nektar Therapeutics Shares 52-Week REZOLVE-AA Data as Rezpeg Boosts SALT ≤20 Responses in Alopecia Areata - Apr 25th, 2026 9:03 am
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Apr 23rd, 2026 2:15 pm
Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering - Apr 21st, 2026 7:30 pm
Nektar (NKTR) Moves 18.3% Higher: Will This Strength Last? - Apr 21st, 2026 8:37 am
Why Nektar Therapeutics Stock Rocked it Today - Apr 20th, 2026 5:33 pm
Nektar Therapeutics Adds To Its 129% Two-Month Run With Alopecia News - Apr 20th, 2026 2:26 pm
Nektar Therapeutics Announces Proposed Public Offering - Apr 20th, 2026 2:01 pm